PPARδ regulates glucose metabolism and insulin sensitivity
Chih‐Hao Lee, Peter Olson, Andrea Lynn Hevener et al. · Proceedings of the National Academy of Sciences · 2006
The metabolic syndrome is a collection of obesity-related disorders. The peroxisome proliferator-activated receptors (PPARs) regulate transcription in response to fatty acids and, as such, are potential therapeutic targets for these diseases. We show that PPARdelta (NR1C2) knockout mice are metabolically less active and glucose-intolerant, whereas receptor activation in db/db mice improves insulin sensitivity. Euglycemic-hyperinsulinemic-clamp experiments further demonstrate that a PPARdelta-specific agonist suppresses hepatic glucose output, increases glucose disposal, and inhibits free fatty acid release from adipocytes. Unexpectedly, gene array and functional analyses suggest that PPARdelta ameliorates hyperglycemia by increasing glucose flux through the pentose phosphate pathway and enhancing fatty acid synthesis. Coupling increased hepatic carbohydrate catabolism with its ability to promote beta-oxidation in muscle allows PPARdelta to regulate metabolic homeostasis and enhance insulin action by complementary effects in distinct tissues. The combined hepatic and peripheral actions of PPARdelta suggest new therapeutic approaches to treat type II diabetes.
Cited by 497 works. doi:10.1073/pnas.0511253103
Authors
- Chih‐Hao Lee
- Peter Olson
- Andrea Lynn Hevener
- Isaac R. Mehl
- Ling-Wa Chong
- Jerrold M. Olefsky
- Frank J. Gonzalez
- Jungyeob Ham
- Heonjoong Kang
- Jeffrey M. Peters
- Ronald M. Evans
References
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
- PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
- PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
- PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
- Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ